131
Bos, J.M., Rietveld, E., Moll, HA, Steyerberg, E.W., Luytjes, W., Wilschut, J.C., de Groot, R., Postma, M.J.
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
132
133
134
135
136
137
Irina V. Chestakova, Anne van der Linden, Beatriz Bellido Martin, Valentina Caliendo, Oanh Vuong, Sanne Thewessen, Tijmen Hartung, Theo Bestebroer, Jasja Dekker, Bob Jonge Poerink, Andrea Gröne, Marion Koopmans, Ron Fouchier, Judith M. A. van den Brand, Reina S. Sikkema
Veröffentlicht in: Emerging Microbes and Infections, Vol 12, Iss 2 (2023);
2023
Veröffentlicht in: Emerging Microbes and Infections, Vol 12, Iss 2 (2023);
2023
138
139
140